The New Criterion: tackling the asthma prevention market is no wheeze Tim Boreham Independent Investment Research
Resmed trial disappoints, but thesis is intact Scott Power Morgans PDF ATTACHED AUS_RMD_150513_Trial_disappoints__but... (277 KB)
